We are live on ! Find out more
OGEN icon

Oragenics

14 hedge funds and large institutions have $2.39M invested in Oragenics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

8% more funds holding

Funds holding: 1314 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

24% less capital invested

Capital invested by funds: $3.15M → $2.39M (-$764K)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
4
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q4 2019 in Review

14 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2019, worth a combined $2.39M — down 24% from $3.15M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $72.2K. The largest seller was Sabby Management, cutting an estimated $133K.

  • 14 institutional investors held Oragenics (OGEN) as of Q4 2019, up from 13 in Q3 2019.
  • Funds reported $2.39M of Oragenics stock for Q4 2019, down 24% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q4 2019 and 1 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q4 2019 was Renaissance Technologies, an estimated $72.2K added.
  • The largest Oragenics seller in Q4 2019 was Sabby Management, an estimated $133K sold.

Based on aggregated 13F filings for Q4 2019.